Abstract
Helicobacter pylori is present in up to 87% of patients with nonulcer dyspepsia. This study assessed the effect of eradicatingHelicobacter pylori infection on the symptoms of nonulcer dyspepsia at four weeks and one year after treatment. Dyspepsia was assessed on the frequency and severity of six symptoms [epigastric pain (night and day), nausea and vomiting, upper abdominal discomfort, and regurgitation] where each symptom was scored from 0 to 4.Helicobacter pylori status was assessed before treatment and four weeks after treatment with histology and microbiology, and at one year with a carbon-13 urea breath test. Eighty-three patients (23 males, 60 females; mean age 56.3 years; mean symptom duration 3.6 months) with nonulcer dyspepsia andHelicobacter pylori infection entered the study. Seventy-five were available at one year follow-up. Four weeks after treatment, the mean symptom score improved in those with eradication (6.95–2.3,P=0.01,N=41) or persistent infection (6.69–3.0,P=0.015,N=42). At one year, those with persistentHelicobacter pylori infection (N=38, score 5.24) had a higher score than those remaining clear of infection (N=24, score 1.4,P<0.0001) and those with reinfection (N=13, score 2.2,P<0.0001). In addition, persistentHelicobacter pylori infection was associated with more additional treatments than those with eradication (34/38 versus 4/37,P<0.001). These results suggest thatHelicobacter pylori plays an important role in the symptoms of nonulcer dyspepsia.
Similar content being viewed by others
References
Warren JR, Marshall BJ: Unidentified curved bacilli on the gastric epithelium in active chronic gastritis. Lancet 1:1273–1275, 1983
Langenberg ML, Tytgat GN, Schipper MEI, Rietra PJGM, Zanen HC:Campylobacter-like organisms in the stomach of patients and healthy individuals. Lancet 1:1348–1349, 1984
Goodwin CS, Armstrong JA, Marshall BJ:Campylobacter pyloridis, gastritis, and peptic ulceration. J Clin Pathol 39:353–365, 1986
Dooley CP, Cohen H: The clinical significance ofCampylobacter pylori. Ann Intern Med 108:70–79, 1988
Petross CW, Appleman MD, Cohen H, Valenzuela JE, Chandrasoma P, Laine LA: Prevalence ofCampylobacter pylori and association with antral mucosal histology in subjects with and without upper gastrointestinal symptoms. Dig Dis Sci 33:649–653, 1988
Rauws EAJ, Langenberg W, Houthoff HJ, Zanen HC, Tytgat GNJ:Campylobacter pyloridis-associated chronic active antral gastritis. Gastroenterology 94:33–40, 1988
Rokkas T, Pursey C, Uzoechina E, Dorrington L, Simmons NA, Filipe MI, Sladen GE: Non-ulcer dyspepsia and short term De-Nol therapy: A placebo controlled trial with particular reference to the role ofCampylobacter pylori. Gut 29:1386–1391, 1988
Loffield RJLF, Stobberingh E, Flendrig JA, Arends JW: Presence ofHelicobacter pylori in patients with non-ulcer dyspepsia revealing normal antral histological characteristics. Digestion 47:29–34, 1990
Marshall BJ, Warren JR: Unidentified curved bacilli in the stomach of patients with gastric and peptic ulceration. Lancet 1:1311–1315, 1984
Timothy T, Schubert MD: Non-ulcer dyspepsia symptoms andHelicobacter pylori. Rev Esp Enferm Dig 78(suppl 1):70, 1990
Gasbarrini G, Pretolani S, Bonvincini F: Clinicopathological correlations withHelicobacter pylori presence in dyspeptic patients. Rev Esp Enferm Dig 78(suppl 1):68, 1990
Loffield RJLF, Adang RPR: Computerized history taking for the assessment ofHelicobacter pylori in non-ulcer dyspepsia? A pilot study. Rev Esp Enferm Dig 78(suppl 1):70–71, 1990
Marshall BJ:Campylobacter pylori: Addressing the controversies. InCampylobacter pylori. H Menge, M Gregor, GNJ Tytgat (eds). Berlin, Springer Verlag, 1988, pp 235–245
Lambert JR, Dunn K, Borromeo M, Korman MC, Hanskey J:Campylobacter pylori—a role in non-ulcer dyspepsia? Scand J Gastroenterol 24(suppl 160):7–13, 1989
Vaira D, Holton J, Falzon M: The benefit of treating dyspeptic patients with normal endoscopic appearances. Rev Esp Enferm Dig 78(suppl 1):106–107, 1990
Patchett S, Beattie S, Leen E, Keane C, O'Morain C: EradicatingHelicobacter pylori and symptoms of non-ulcer dyspepsia. Br Med J 303:1238–1240, 1991
Logan RPH, Dill S, Bauer FE, Walker MM, Hirschl AM, Gummett PA, Good D, Mossi S: The European standard13C-urea breath test for the detection ofHelicobacter pylori. Eur J Gastroenterol Hepatol 3:915–921, 1991
Bell GD, Powell KU, Burridge SM, Harrison G, Rameh B, Weil J, Gant PW, Jones PH, Trowell JE: Reinfection of recrudescence after apparently successful eradication ofHelicobacter pylori infection: Implications for treatment of patients with duodenal ulcer disease. Q J Med 86:375–382, 1993
Talley NJ: Non-ulcer dyspepsia: Myths and realities. Aliment Pharmacol Ther 5(suppl):145–162, 1991
Heading RC: Definitions of dyspepsia. Scand J Gastroenterol 26(suppl 182):1–6, 1991
Marshall BJ, McGechie DB, Rogers PA, Glancy RJ: PyloricCampylobacter infection and gastroduodenal disease. Med J Aust 142:439–444, 1985
Parsonett J, Blaser MJ, Perez-Perez GI, Hargrett-Bean N, Tauxe RV: Symptoms and risk factors ofHelicobacter pylori infection in a cohort of epidemiologists. Gastroenterology 102:41–46, 1992
Loffield RJLF, Potters HV, Stobberingh E, Flendrig JA, van Spreeuwel JP, Arends JW:Campylobacter associated gastritis in patients with non-ulcer dyspepsia: A double blind placebo controlled trial with colloidal bismuth subcitrate. Gut 80:1206–1212, 1989
Marshall BJ, Valenzuela JE, McAllum RW, Dooley CP, Guerrant RL, Cohen H: A placebo controlled clinical trial of bismuth subsalicylate for the treatment ofHelicobacter pylori associated gastritis. Gastroenterology 98(suppl):A83, 1990
Katelaris PH, Tippett GHK, Norbu P, Lowe DG, Brennan R, Farthing MJG: Dyspepsia,Helicobacter pylori and peptide ulcer in a randomly selected population in India. Gut 33:1462–1466, 1992
Bernesen B, Johnsen R, Bostad L, Straume B, Sommer AI, Burhol PG: IsHelicobacter pylori the cause of dyspepsia. Br Med J 304:1276–1279, 1992
Dooley CP, Cohen H, Fitzgibbons PL, Bauer M, Appleman MD, Perez-Perez GI, Blaser MJ: Prevalence ofHelicobacter pylori infection in asymptomatic persons. N Engl J Med 321:1562–1566, 1989
Barthel JS, Westblom TU, Havey AD, Gonzales F, Everett DE: Gastritis andCampylobacter pylori in healthy asymptomatic volunteers. Arch Intern Med 148:1149–1151, 1988
Morris A, Nicholson G: Ingestion of Campylobacter pyloridis causes gastritis and a raised fasting pH. Am J Gastroenterol 82:192–199, 1987
Ramsay EJ, Carey KV, Peterson WL, Jackson JJ, Murphy FK, Read NWT: Epidemic gastritis with hypochlorhydria. Gastroenterology 76:1449–1457, 1979
Gledhill T, Leicester RJ, Addis B, Lightfoot N, Barnard J, Viney N: Epidemic hypochlorhydria. Br Med J 290:1383–1386, 1985
Adami HO, Agenäs I, Gustavsson S, Lööf L, Nyberg A, Nyrén O: The clinical diagnosis of “gastritis.” Scand J Gastroenterol 19:216–219, 1984
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
McCarthy, C., Patchett, S., Collins, R.M. et al. Long-term prospective study ofHelicobacter pylori in nonulcer dyspepsia. Digest Dis Sci 40, 114–119 (1995). https://doi.org/10.1007/BF02063953
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02063953